---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-22-035693"
form_type: "8-K"
ticker: "ATNM"
cik: "0001388320"
company_name: "Actinium Pharmaceuticals, Inc."
filed_at: "2022-06-29T23:59:59+00:00"
generated_at: "2026-06-24T22:19:04.147710+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Actinium amends at-the-market sales agreement, adds B. Riley Securities as agent

## Summary
- Original Capital on Demand Sales Agreement (Aug 2020) allowed up to $200M in ATM offerings via JonesTrading.
- A&R Sales Agreement dated June 28, 2022 adds B. Riley Securities as an additional sales agent.
- No other material changes to terms; remaining $200M capacity unaffected.
- Agreement filed as Exhibit 1.1; representations are for parties only, not factual disclosures.

## SEC filing metadata
- accession: 0001213900-22-035693
- form_type: 8-K
- ticker: ATNM
- cik: 0001388320
- company_name: Actinium Pharmaceuticals, Inc.
- filed_at: 2022-06-29T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1388320/000121390022035693/0001213900-22-035693-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1388320/000121390022035693/ea161465-8k_actinium.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-22-035693
- JSON: https://secwatch.observer/filing/0001213900-22-035693.json
- Plain text: https://secwatch.observer/filing/0001213900-22-035693.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.